Log in or Sign up for Free to view tailored content for your specialty!
Pancreatic Disorders News
Nine updates for World Pancreatic Cancer Day
World Pancreatic Cancer Day will be observed today.
Novel treatment device safe, effective for early pancreatic cancer
Researchers at Virginia Commonwealth Massey Cancer Center became the first to implant the bio-absorbable internal radiation device known as CivaSheet for the treatment of early-stage pancreatic cancer.
Log in or Sign up for Free to view tailored content for your specialty!
CHARM: Ethanol-free EUS-guided chemoablation safe, effective
ORLANDO — An ethanol-free protocol for pancreatic cyst ablation followed by a combined paclitaxel and gemcitabine regimen for pancreatic neoplasia was effective and led to significant reductions in adverse events, according to research presented at the World Congress of Gastroenterology at ACG 2017.
Genetic test shows promise for identifying pancreatic cysts at high risk for cancer
A novel genetic testing strategy developed at University of Pittsburgh Medical Center, which sequences mutations in pancreatic cyst fluid before surgery, showed high accuracy for identifying cysts associated with a high risk for aggressive pancreatic cancer.
Laparoscopic surgery for pancreatic cancer cuts hospital stays by half
Patients with pancreatic cancer who underwent pancreatoduodenectomy, also known as the Whipple procedure, experienced shorter hospital stays with laparoscopic vs. open surgery in a randomized controlled trial.
Penn appoints GI professor as director of pancreatic cancer research
University of Pennsylvania announced that Ben Z. Stanger, MD, PhD, associate professor of gastroenterology in the Perelman School of Medicine, has been appointed director of the Penn Pancreatic Cancer Research Center.
‘Type 3c diabetes’ may be more common than type 1
A diagnosis of diabetes following pancreatic disease is often classified as type 2 diabetes but presents with worse glycemic control and a higher need for insulin, according to findings published in Diabetes Care.
Akcea, Ionis file NDA for familial chylomicronemia syndrome drug
Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, announced it has submitted a new drug application to the FDA for volanesorsen, an investigational drug treatment for familial chylomicronemia syndrome.
Smartphone app could detect pancreatic cancer using ‘selfies’
A new smartphone app called BiliScreen showed promise for pancreatic cancer screening by analyzing signs of jaundice in photos of a user’s eyes.
High pancreatic fat content may lead to insulin dependence
Insulin dependence was common among adults with increased pancreatic fat content who underwent total pancreatectomy with islet autotransplantation, and the condition may lead to beta-cell dysfunction, according to findings published in the Journal of Diabetes.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read